Compare PKE & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PKE | BVS |
|---|---|---|
| Founded | 1954 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 796.7M | 783.2M |
| IPO Year | 1994 | 2016 |
| Metric | PKE | BVS |
|---|---|---|
| Price | $35.76 | $12.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | 308.5K | ★ 666.3K |
| Earning Date | 05-15-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.53% | N/A |
| EPS Growth | 93.10 | ★ 163.46 |
| EPS | ★ 0.17 | 0.04 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | N/A | $7.52 |
| Revenue Next Year | N/A | $7.06 |
| P/E Ratio | ★ $201.41 | $295.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $17.25 | $5.81 |
| 52 Week High | $39.86 | $12.53 |
| Indicator | PKE | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 55.13 | 62.84 |
| Support Level | $31.16 | $8.04 |
| Resistance Level | $36.51 | $12.53 |
| Average True Range (ATR) | 2.08 | 0.54 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 49.76 | 80.43 |
Park Aerospace Corp is an aerospace company that develops and manufactures composite materials used to produce composite structures for the aerospace market. Its products include film adhesives, lightning strike protection materials, specialty ablative materials for rocket motors and nozzles, and materials for radome applications. The Company offers composite materials designed for hand lay-up and automated fiber placement (AFP) manufacturing applications, which are used in jet engines, large and regional transport aircraft, military aircraft, unmanned aerial vehicles (UAVs), business jets, general aviation aircraft, and rotary wing aircraft. It operates in North America, Asia, and Europe, with North America generating maximum revenue.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.